U2BIO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,400 KRW | +5.52% |
|
+7.06% | -16.67% |
| 2023 | U2Bio Co., Ltd. has filed an IPO. | CI |
| 2020 | Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion. | CI |
More news
| 1 day | +5.52% | ||
| 1 week | +7.06% | ||
| Current month | +14.43% | ||
| 1 month | +17.18% | ||
| 3 months | -4.56% | ||
| 6 months | -16.67% | ||
| Current year | -16.67% |
1 week
3 810.00
4 475.00
1 month
3 725.004 475.00
Current year
3 720.005 690.00
1 year
3 720.0010 950.00
3 years
2 275.0010 950.00
5 years
1 810.0010 950.00
10 years
1 810.0010 950.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jin-Tae Kim
CEO | Chief Executive Officer | 60 | 09-10-31 |
Ji-Won Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | 10-12-31 |
Hyuk-Sung Jin
BRD | Director/Board Member | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jang-Ho Park
BRD | Director/Board Member | 53 | - |
Jin-Tae Kim
CEO | Chief Executive Officer | 60 | 09-10-31 |
Ji-Won Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | 10-12-31 |
U2BIO CO., LTD. is a Korea-based company mainly engaged in the provision of diagnostic testing services. The Company is involved in the provision of the general diagnostic testing services, molecular diagnostic testing services, as well as medical information technology (IT) services. The general diagnostic testing services include the provision of diagnosis and inspection information such as immunological serology, hematology, urine and microbiology, and pathology excluding molecular diagnostics among in vitro diagnostic tests. The Molecular diagnostic testing services include the provision of diagnostic and testing information through tests such as urethritis, mastoiditis, vaginitis, and cervicitis. The medical IT services include the provision of customized medical services through software products.
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.67% | 34.46M | |
| +16.49% | 83.4B | |
| -29.52% | 72.11B | |
| 0.00% | 27.04B | |
| -13.29% | 16.96B | |
| +1.03% | 16.86B | |
| +1.57% | 15.76B | |
| +71.63% | 13.33B | |
| +1.53% | 12.76B | |
| +70.68% | 12.74B |
- Stock Market
- Equities
- A221800 Stock
